Multicenter Mpact DM France
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorMedacta International SA
About this trial
The primary objective of the study is to evaluate the 10-year performance of the MPACT DM cup in the treatment of patients requiring total hip arthroplasty.
The primary endpoint is the 10-year life span of the prosthesis according to the Kaplan Meier curve.
Eligibility criteria
Qualifiers
Patient with a disease that meets the indications for use of Medacta implants (according to the instructions for use)
Patient eligible for first-line total hip replacement
Patient between 18 and 80 years of age
Patient covered by the Social Security system or an equivalent protection plan
Disqualifiers
Patient requiring a transplant
Patient with progressive local or systemic infection
Patient with muscle loss, neuromuscular disease, or vascular impairment of the affected limb making surgery unwarranted
Patient with known medical problems that may compromise independent recovery of mobility
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov